These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 18688173

  • 1. Prolongation of corneal allograft survival by topical application of everolimus in experimental keratoplasty.
    Li XQ, Buch G, Otasevic L, Schlickeiser S, Bertelmann E, Pleyer U.
    Ophthalmic Res; 2008 Oct; 40(6):309-14. PubMed ID: 18688173
    [Abstract] [Full Text] [Related]

  • 2. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
    Ritter T, Yang J, Dannowski H, Vogt K, Volk HD, Pleyer U.
    Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
    [Abstract] [Full Text] [Related]

  • 3. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
    Hikita N, Lopez JS, Chan CC, Mochizuki M, Nussenblatt RB, de Smet MD.
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
    [Abstract] [Full Text] [Related]

  • 4. Effect of topically applied anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model.
    Pleyer U, Milani JK, Dukes A, Chou J, Lutz S, Rückert D, Thiel HJ, Mondino BJ.
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):52-61. PubMed ID: 7822159
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL, Lallemand F, Agla E, Besseghir K, Dumont JM, BenEzra D, Gurny R, Behar-Cohen F.
    Mol Vis; 2006 Dec 02; 12():1461-6. PubMed ID: 17167400
    [Abstract] [Full Text] [Related]

  • 6. Effects of a selective glucocorticoid receptor agonist on experimental keratoplasty.
    Pleyer U, Yang J, Knapp S, Schäcke H, Schmees N, Orlic N, Otasevic L, De Ruijter M, Ritter T, Keipert S.
    Graefes Arch Clin Exp Ophthalmol; 2005 May 02; 243(5):450-5. PubMed ID: 15821926
    [Abstract] [Full Text] [Related]

  • 7. Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment.
    Torres PF, Slegers TP, Peek R, van Rooijen N, van der Gaag R, Kijlstra A, de Vos AF.
    Invest Ophthalmol Vis Sci; 1999 Dec 02; 40(13):3194-201. PubMed ID: 10586942
    [Abstract] [Full Text] [Related]

  • 8. Promotion of corneal allograft survival with leflunomide.
    Niederkorn JY, Lang LS, Ross J, Mellon J, Robertson SM.
    Invest Ophthalmol Vis Sci; 1994 Sep 02; 35(10):3783-5. PubMed ID: 8088966
    [Abstract] [Full Text] [Related]

  • 9. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH, Yan Y, De Boer B, Bishop GA, House AK.
    Transplantation; 2003 Feb 15; 75(3):368-74. PubMed ID: 12589161
    [Abstract] [Full Text] [Related]

  • 10. Local overexpression of nerve growth factor in rat corneal transplants improves allograft survival.
    Gong N, Pleyer U, Vogt K, Anegon I, Flügel A, Volk HD, Ritter T.
    Invest Ophthalmol Vis Sci; 2007 Mar 15; 48(3):1043-52. PubMed ID: 17325145
    [Abstract] [Full Text] [Related]

  • 11. Survival of corneal allografts following topical treatment with the immunomodulator mycophenolate mofetil.
    Bertelmann E, de Ruijter M, Gong N, Knapp S, Pleyer U.
    Ophthalmologica; 2010 Mar 15; 224(1):38-41. PubMed ID: 19672124
    [Abstract] [Full Text] [Related]

  • 12. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
    Tran HS, Malli D, Chrzanowski FA, Puc MM, Matthews MS, Hewitt CW.
    J Surg Res; 1999 May 15; 83(2):136-40. PubMed ID: 10329107
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats].
    Zhang W, Pan Z, Zhai C.
    Zhonghua Yan Ke Za Zhi; 2001 Mar 15; 37(2):140-3. PubMed ID: 11864411
    [Abstract] [Full Text] [Related]

  • 14. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
    Shi W, Gao H, Xie L, Wang S.
    Invest Ophthalmol Vis Sci; 2006 Aug 15; 47(8):3339-44. PubMed ID: 16877400
    [Abstract] [Full Text] [Related]

  • 15. [Effects of anti-CD25 monoclonal antibody on the level of cytokines in aqueous humour after rat penetrating keratoplasty].
    Gong YB, Lu XH, Ke XY, Zhou J, Yuan W, Tang MF, Luo XY, Cui GH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug 15; 28(9):1523-9. PubMed ID: 18819859
    [Abstract] [Full Text] [Related]

  • 16. [Sustained rapamycin drug delivery system in prevention of high risk corneal allograft rejection and neovascularization in rabbits].
    Gao H, Shi WY, Xie LX, Wang SG.
    Zhonghua Yan Ke Za Zhi; 2006 Jan 15; 42(1):6-11. PubMed ID: 16638273
    [Abstract] [Full Text] [Related]

  • 17. Topical FK-506 prevents experimental corneal allograft rejection.
    Mills RA, Jones DB, Winkler CR, Wallace GW, Wilhelmus KR.
    Cornea; 1995 Mar 15; 14(2):157-60. PubMed ID: 7538061
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses.
    Majewski M, Korecka M, Joergensen J, Fields L, Kossev P, Schuler W, Shaw L, Wasik MA.
    Transplantation; 2003 May 27; 75(10):1710-7. PubMed ID: 12777861
    [Abstract] [Full Text] [Related]

  • 19. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
    Shi W, Xie L, Wang S.
    Zhonghua Yan Ke Za Zhi; 2002 Aug 27; 38(8):502-5. PubMed ID: 12410993
    [Abstract] [Full Text] [Related]

  • 20. [Experimental studies on the effect of the immunosuppressant FK-506 on penetrating keratoplasty rejection model in rats].
    Lü L, Zhang W, Sun X.
    Zhonghua Yan Ke Za Zhi; 1999 Jan 27; 35(1):25-8. PubMed ID: 11835769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.